ABOUT DIVYA NAG
Divya Nag is a futurist.
A dreamer, do-er, darer.
An avid supporter of women in science and technology.
A world traveler with an Achilles heel for historic architecture and paperback books.
Nag co-authored two dozen publications on stem cell technologies at the Stanford Institute for Stem Cell Biology and Regenerative Medicine and dropped out of Stanford at the age of 20 to found Stem Cell Theranostics, a biotechnology company committed to revolutionizing the drug discovery process by performing the first “clinical trial in a dish” through the use of patient-specific beating heart cells derived from skin.
She also founded StartX Med, Stanford University and Stanford Hospital’s non-profit medical innovation accelerator program that has helped more than 100 health technology companies launch and raise over $400M. Divya joined Apple’s Special Projects group in 2014.
Divya has been named the 2nd Most Creative Person in Business by Fast Company, included on the Silicon Valley Top 100 Innovators and Disruptors list, selected as Forbes 30 under 30 standout in Science & Healthcare, and highlighted by Business Insider as one of the Most Powerful Millennials under 35.
- The Health Care 50
- Divya Nag-40 Under 40-Fortune
- Most Creative People in Business
- The Silicon Valley 100: The Most Amazing and Inspiring People in Tech Right Now
- 30 under 30: Science and Healthcare
- Meet the Millennial Shaking up US Medicine
- Sacramento Area Science Wunderkid
- 21-Year-Old Biotech Leader
- Three Indian Americans Among TIME Health Care 50 Honorees for Extraordinary Innovation
- Hot 20: The Prodigy
- 30 Most Important Women Under 30
- Women Changing the World
- Most Powerful Millennials Under 35
- StartX Med Prescribed for Innovation
Silicon Valley Business Journal
- The 25 Coolest Women in Silicon Valley
The Biotech Pioneer That Can Rebuild Your Heart Cells – Forbes
ResearchKit – Empowering doctors, researchers, and now you – Apple Keynote
2014 State of the Valley – “TED-style” Talk-Divya Nag – State of the Valley
Divya Nag | TCWEEK Vegas Sessions | 11.2013 – Vegas Tech Week
Divya Nag-Benefits of Multidisciplinary Exposure – Stanford Thought Leaders
Divya Nag on Catalyst@Berkeley – Berkeley Medical Innovation
Most Influential Industry Leaders in Healthcare of 2019Industry Leaders (2019)
Antibody on Human Pluripotent Stem Cells Enables Removing of Teratoma-Forming CellsNature Biotechnology (2011)
Safe Genetic Modification of Cardiac Stem Cells Using Site-Specific Integration TechniqueCirculation (2012)
Novel Prosurvival Cocktail for Improving Function of Cardiac Progenitor Cell TransplantationCirculation (2011)
In Vivo Directed Differentiation of Pluripotent Stem Cells to Bone and Repair of a Skeletal DefectJournal of Surgical Research (2012)
Human Cardiac Progenitor Cells Engineered with Pim-1 Kinase Enhance Myocardial RepairJournal of American College of Cardiology (2012)
Cell Transplantation and Tissue RegenerationCirculation (2012)
Early Stem Cell Engraftment Predicts Late Cardiac Functional Recovery- Insights from ImagingCirculation: Cardiovascular Imaging (2012)
Clonal Precursor of Bone, Cartilage, and Hematopoietic Niche Stromal CellsProceedings of the National Academy of Sciences (2013)
Efficient gene delivery of primary human cells using peptide linked polyethylenimine polymer hybridBiomaterials 32 (20), 4647-4658